Giant mitochondria in human liver disease

Area of Science:

• Hepatology
• Cell Biology
• Pathology

Background:

• Giant mitochondria (megamitochondria) are pathological hallmarks in liver parenchymal cells.
• Their accumulation signifies cellular damage, potentially leading to liver tissue deterioration and organ failure.
• First described in the 1960s, they are observed in various liver diseases, including alcoholic and non-alcoholic fatty liver disease, chronic hepatitis, and hepatocellular carcinoma.

Purpose of the Study:

• To review the current knowledge on giant mitochondria in liver parenchymal cells.
• To explore their ultrastructure, occurrence, and association with liver diseases.
• To discuss their diagnostic importance and future research directions.

Main Methods:

• Thematic review of existing literature.
• Analysis of ultrastructural descriptions from various liver disease contexts.
• Discussion of proposed formation mechanisms and potential roles.

Main Results:

• Giant mitochondria can occur with or without organized crystal-like intramitochondrial inclusions.
• Their origin, formation mechanisms, and precise role in liver pathology remain largely unknown.
• The biochemical composition and functional impact of associated inclusions are unclear.

Conclusions:

• Giant mitochondria are significant indicators of liver parenchymal cell damage and disease progression.
• Further research is needed to elucidate their formation, function, and the nature of intramitochondrial inclusions.
• Understanding giant mitochondria may offer future diagnostic and therapeutic strategies for liver diseases.